Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Industry pursues co-stimulatory receptor immunomodulators to treat cancer.

Literature DB >> 23471048

Industry pursues co-stimulatory receptor immunomodulators to treat cancer.

Cormac Sheridan.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 23471048 DOI： 10.1038/nbt0313-181

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

8 in total

1. What's fueling the biotech engine--2010 to 2011.

Authors: Saurabh Aggarwal
Journal: Nat Biotechnol Date: 2011-12-08 Impact factor: 54.908

2. TeGenero fiasco prompts regulatory rethink.

Authors: Cormac Sheridan
Journal: Nat Biotechnol Date: 2006-05 Impact factor: 54.908

3. Bristol-Myers Squibb swallows last of antibody pioneers.

Authors: Malorye Allison
Journal: Nat Biotechnol Date: 2009-09 Impact factor: 54.908

4. Cautious optimism surrounds early clinical data for PD-1 blocker.

Authors: Cormac Sheridan
Journal: Nat Biotechnol Date: 2012-08 Impact factor: 54.908

5. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors: Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal: Nat Immunol Date: 2002-01-22 Impact factor: 25.606

6. OX40 ligand shuts down IL-10-producing regulatory T cells.

Authors: Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Shino Hanabuchi; Olivia A Perng; Michel Gilliet; F Xiao-Feng Qin; Yong-Jun Liu
Journal: Proc Natl Acad Sci U S A Date: 2006-08-21 Impact factor: 11.205

Review 7. Control of immunity by the TNFR-related molecule OX40 (CD134).

Authors: Michael Croft
Journal: Annu Rev Immunol Date: 2010 Impact factor: 28.527

8. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.

Authors: Kaori Sakuishi; Lionel Apetoh; Jenna M Sullivan; Bruce R Blazar; Vijay K Kuchroo; Ana C Anderson
Journal: J Exp Med Date: 2010-09-06 Impact factor: 14.307